The board of directors of PerceptiMed, Inc., the Silicon Valley based pharmacy technology company, today announced that Frank Starn has been appointed CEO of the rapidly growing company.
Citing the success the company is having with its scripClip™ pick-to-light will call system, Dr. Rod Markin, PerceptiMed chairman, said the time had come for the company to bring on a CEO with a proven track record of success and with the industry knowledge and relationships to accelerate the company’s growth.
Starn served for 12 years in senior management positions with McKesson Corporation, the nation’s largest supplier of pharmaceuticals and related technology to pharmacies of all types. Starn was most recently senior vice president and COO of McKesson’s U.S. Pharmaceuticals Distribution Group. Prior to this, he served as president of Global Sourcing as well as senior vice president and CFO of the U.S. Pharmaceuticals Group. Prior to McKesson, Starn served as a senior executive at Whirlpool Corporation in the U.S., China, and Europe.
Starn will assume his duties immediately. Bob Curry the outgoing CEO, who has 32 years of healthcare venture capital investing experience, will continue to serve on the board. Markin said PerceptiMed is excited to have Starn join the Company and looks forward to PerceptiMed’s continued rapid growth.